Download to read offline
Uploaded byEdwin Rojas
CIP DOI Presentation by Dave Ellis
This document discusses the use of digital object identifiers (DOIs) to track accessions within genebank collections and their transfers between institutions. It presents some options for assigning DOIs, such as assigning a new DOI with each transfer or only when needed. It also discusses challenges like ensuring genetic identity and fidelity given reports of mixes in some collections. While DOIs alone may not solve all problems, they could help identify when issues occur and allow linking genetic data to accessions over time. For the global information system to be effective, genebanks must ensure DOIs work well and convince users of their benefits through demonstration of impact on users.
CIP DOI Presentation by Dave Ellis
- 1. INIA-CIP taller sobreGLIS 08 Feb 2018 La perspectiva de un clone para los DOI Dave Ellis Head of Genebank Leader of the Program for Conserving Biodiversity for the Future
- 2. DOIs - Opcionescomplementarias • Estado basal: • 100% In Trust accessions assigned DOIs • 100% accessions in MLS assigned DOIs? • Asignar nuevos DOI cada nuevo SMTA • Every transfer gets new DOI to recipient material • If purpose is tracking, this will help • 90%+ DOIs will be dead ends • Cada cultivo/uso determina cuándo o si se asigna un nuevo DOI • Only assign new DOIs when needed or useful • Require compliance and understanding by users
- 3. Que son DOIs doi.org/10.18730/CKR7 doi.org/10.18730/CR94 doi.org/10.18730/9058 doi.org/10.18730/92F8 doi.org/10.18730/963D doi.org/10.18730/9CZB doi.org/10.18730/9F57 doi.org/10.18730/9KF$ doi.org/10.18730/9KJ0 doi.org/10.18730/9W1C doi.org/10.18730/9W2D doi.org/10.18730/9ZA6 CIP706775 CIP 707011 CIP 700739 CIP 701013 CIP 701531 CIP 702407 CIP 702698 CIP 703296 CIP 703299 CIP 703648 CIP 703649 CIP 703765
- 4. Selecciones basadas ensemillas 50 seed each X F1 = 10K-100K undesirable plants 10% best back-crossed to parent 1-15 F6-15 seed lots to multifield trials DOI 1 DOI 2 DOI 3 Sharing of pre- breeding F1 seed DOI 4-9 Sharing of intermediate F2-10 seed DOI 9-25
- 5. ¡Aquí vienen losclones! DOI 3 DOI 4 2 clones After ~3 yrs testing, can an select F1 for multifield trials DOI 5 DOI 6 DOI 7 DOI 8 DOI 9 DOI 10 X DOI 11 DOI 12 DOI 13 NARS 1 selects lines NARS 2 selects lines DOI 14 DOI 15 DOI 14 LEFT OVER SEED?
- 6. Después de losensayos de campo, los clones seleccionados son liberados por NARSDOI 5 DOI 6 & 11 DOI 7 DOI 8 DOI 9 &14 DOI 10 & 15 DOI 16 DOI 17 NARS 2 DOI 6 & 11 DOI 10 & 15 DOI 18 DOI 9 &14 DOI 7 DOI 19 DOI 18 & 20 DOI 19 & 22 DOI 16 & 21 DOI 17 & 23 NARS 1 DOI 6 & 11 DOI 8 DOI 10 & 15 ONG 1 DOI 6 & 11 DOI 10 & 15 DOI 20 DOI 7 DOI 22 DOI 23 DOI 8 DOI 21
- 7. ¿Cuál es elestado de las colecciones? • Increasing reports of mixes in GR collections • Arabidopsis seed germplasm, genetic stocks, mapping populations, tagged lines, etc. • Not unique to plants – also huge challenge in medical and microbial fields • The GLIS is only as good as the information provided to it • Errors not only jeaprodize the GLIS but also the BSF • If there is distrust, people will not use it
- 8. Fidelidad de germoplasma Year1 DOI 1 DOI 1 DOI 1 Nature Science PNAS Whose Reputation is on the line? 1o donor? 2o donor? Authors? System? DOI 1 DOI 2DOI 1 DOI 1
- 9.
- 10. ¿Cuándo y cómoocurren los errores? • Absolutely no clue when or how the mix- ups happened • No correlation with anything we can find • All collections affected – todos • If the Material is wrong, the associated information may also be wrong • And the information in GLIS will be wrong
- 11. DOIs y laverificacion de identidad • Would DOIs have helped our misidentity situation? • Likely, no • However DOIs would have allowed us to know when this problem happened! • The entire in vitro (clonal) CIP potato and sweetpotato collections are now DNA fingerprinted • Enabling DOIs to be linked to these DNA fingerprints into perpetuity • This will add genetic fidelity to the GLIS
- 12. ¡SOMOS RESPONSABLES! • DOIsare a tool for tracking use and related information – measure impact • Currently, we lack tools to do this • DOIs may not be the panacea – they will not solve all our problems – but they are a first step! • A year ago, I argued publicly against DOIs • As a genebank manager, I now see a need, value and justification for a GLIS
- 13. En resumen • Itis in our best interests to ensure DOIs work • It will not be “If we build it they will come” • It will be a very, very hard sell to fully implement • We will have to take users by the hand, pamper them, bribe them, show it to them • Look at the “easy SMTA” • We need to show users the benefit of using DOIs = show impact • How will it help users? • Talk is not enough • For me, >60% tracking & <40% identity